Abstract
The adeno-associated virus 2 (AAV2) is known to possess a broad host-range that transcends the species barrier (1). The broad host-range and nonpathogenic nature of AAV, coupled with its site-specificity and stable integration of the pro viral genome, have led to the development of recombinant AAV vectors (2). Recombinant AAV vectors have been shown to transduce certain cell types, such as muscle and brain, exceedingly well (3–5). However, controversies exist with regard to the efficacy of AAV vectors in transducing human hematopoietic stem cells (6). Whereas some investigators have concluded that AAV vectors do not transduce human hematopoietic cells at all (7), other reports have documented the need for enormously high multiplicities of infection (MOIs) by AAV vectors for successful transduction (8–13). Several groups, including my own, have reported successful transduction of these cells at relatively low MOIs (14–17). Some of these controversies have been addressed in a recent review article (18).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Muzyczka, N. (1992) Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97–129.
Berns K. I. and Giraud, A. (1996) Biology of adeno-associated virus. Curr. Top. Microbiol. Immunol. 218, 1–23.
Xiao, X., Li, J., and Samulski, R. J. (1996) Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098–8108.
Kessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P. A., Matelis, L.A., et al. (1996) Gene delivery to skeletal muscle results in sustained and expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93, 14082–14087.
Kaplitt, M. G., Leone, P., Samulski, R. J., Xiao, X., Pfaff, D. W., O’Malley, K. L., and During, M. J. (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148–153.
Russell, D. W. and Kay, M. A. (1999) Adeno-associated virus vectors and hematology. Blood 94, 864–874.
Alexander, I. A., Russell, D. W., and Miller, A. D. (1997) Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results. Hum. Gene Ther. 8, 1911–1920.
Goodman, S., Xiao, X., Donahue, R. E., Moulton, A., Miller, J. L., Walsh, C. E., et al. (1994) Recombinant adeno-associated virus mediated gene transfer into hematopoietic progenitor cells. Blood 84, 1492–1500.
Miller, J. L., Donahue, R. E., Sellers, S. E., Samulski, R. J., Young, N. S., and Nienhuis, A. W. (1994) Recombinant adeno-associated virus (rAAV)-mediated expression of human γ-globin gene in human progenitor-derived erythroid cells. Proc. Natl. Acad. Sci. USA 91, 10183–10187.
Walsh, C. E., Nienhuis, A. W., Samulski, R. J., Brown, M. G., Miller, J. L., Young, N. S., Liu, J. M. (1994) Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J. Clin. Invest. 94, 1440–1448.
Malik, P., McQuiston, S. A., Yu, X.-J., Pepper, K. A., Krall, W. J., Podsakoff, G. M., et al. (1997) Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in K562 human hematopoietic cell line. J. Virol. 71, 1776–1783.
Hargrove, P. W., Vanin, E. F., Kurtzman, G. J., and Nienhuis, A. W. (1997) High-level globin gene expression mediated by a recombinant adeno-associated virus genome that contains the 3′ γ globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood 89, 2167–2175.
Nathwani, A. C., Hanawa, H., Vandergriff, J., Kelly, P., Vanin, E. F., and Nienhuis, A. W. (2000) Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector that are free of helper virus and wild-type AAV. Gene Ther. 7, 183–195.
Zhou, S. Z., Cooper, S., Kang, L. Y., Ruggieri, L., Heimfeld, S., Srivastava, A., and Broxmeyer, H. E. (1994) Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J. Exp. Med. 179, 1867–1875.
Fisher-Adams, G., Wong, K. K., Podsakoff, G. M., Forman, S. J., and Chatterjee, S. (1996) Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. Blood 88, 492–504.
Chatterjee, S., Li, W., Wong, C. A., Fisher-Adams, G., Lu, D., Guha, M., et al. (1999) Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors. Blood 93, 1882–1894.
Luhovy, M., McCune, S., Dong, J.-Y, Prchal, J. F., Townes, T. M., and Prchal, J. T. (1996) Stable transduction of recombinant adeno-associated virus into hematopoietic stem cells from normal and sickle cell patients. Biol. Blood Marrow Transpl. 2, 24–30.
Srivastava, A. (2002) Obstacles to human hematopoietic stem cell transduction by recombinant adeno-associated virus 2 vectors. J. Cell. Biochem. 38, 39–45.
Ponnazhagan, S., Mukherjee, P., Wang, X.-S., Qing, K. Y., Kube, D. M., Mah, C., et al. (1997) Adeno-associated virus type 2-mediated transduction of primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation. J. Virol. 71, 8262–8267.
Ponnazhagan, S., Mukherjee, P., Yoder, M. C., Wang, X.-S., Zhou, S. Z. Kaplan, J., et al. (1997) Adeno-associated virus 2-mediated gene transfer in vivo: organ-tro-pism and expression of transduced sequences in mice. Gene 190, 203–210.
Ponnazhagan, S., Yoder, M. C., and Srivastava, A. (1997) Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo. J. Virol. 71: 3098–3104.
Tan, M. Q., Qing, K. Y., Zhou, S. Z., Yoder, M. C., and Srivastava, A. (2001) Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted, long-term expression of the normal human β-globin gene in hematopoietic cells from homozygous β-thalassemic mice. Mol. Ther. 3, 940–946.
Yoder, M. C., Du, X.-X. and Williams, D. A. (1993) High proliferative potential colony-forming cell heterogeneity identified using counterflow centrifugal elutriation. Blood 82, 385–391.
Yoder, M. C., King, B., Hiatt, K., Mukherjee, P., and Williams, D. A. (1995) Growth of bone marrow high-proliferative potential colony-forming cells during in vitro co-culture with murine embryonic yolk sac cell lines. Blood 86, 1322–1330.
Zolotukhin, S., Byrne, B. J., Zolotukhin, I., Summerford, C., Samulski, R. J., and Muzyczka, N. (1999) Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973–985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Srivastava, A. (2004). Gene Delivery to Human and Murine Primitive Hematopoietic Stem and Progenitor Cells by AAV2 Vectors. In: Heiser, W.C. (eds) Gene Delivery to Mammalian Cells. Methods in Molecular Biology™, vol 246. Humana Press. https://doi.org/10.1385/1-59259-650-9:245
Download citation
DOI: https://doi.org/10.1385/1-59259-650-9:245
Publisher Name: Humana Press
Print ISBN: 978-1-58829-095-3
Online ISBN: 978-1-59259-650-8
eBook Packages: Springer Protocols